stoxline Quote Chart Rank Option Currency Glossary
  
Microbot Medical Inc. (MBOT)
2.15  0.12 (5.91%)    02-12 19:59
Open: 2.01
High: 2.155
Volume: 2,119,380
  
Pre. Close: 2.03
Low: 2
Market Cap: 62(M)
Technical analysis
2025-02-12 4:46:21 PM
Short term     
Mid term     
Targets 6-month :  3.1 1-year :  3.62
Resists First :  2.66 Second :  3.1
Pivot price 2.07
Supports First :  1.9 Second :  1.44
MAs MA(5) :  2.32 MA(20) :  2.01
MA(100) :  1.26 MA(250) :  1.13
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  47.7 D(3) :  63.9
RSI RSI(14): 55.1
52-week High :  3.38 Low :  0.81
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MBOT ] has closed below upper band by 42.5%. Bollinger Bands are 82% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.16 - 2.17 2.17 - 2.18
Low: 1.97 - 1.99 1.99 - 2
Close: 2.13 - 2.15 2.15 - 2.17
Company Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Headline News

Wed, 12 Feb 2025
Microbot Medical raises funds and anticipates FDA clearance - MSN

Tue, 11 Feb 2025
Microbot Medical Closes $13 Million Registered Direct Offering - GlobeNewswire

Tue, 11 Feb 2025
Strategic $13M Funding Fuels Microbot Medical's Robotics Innovation: LIBERTY® System Development Accelerates - StockTitan

Mon, 10 Feb 2025
Microbot Medical to Sell Common Stock Worth $13 Million -February 10, 2025 at 12:17 pm EST - Marketscreener.com

Mon, 10 Feb 2025
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - GlobeNewswire

Mon, 10 Feb 2025
Microbot Medical Secures Critical $13M Funding to Accelerate Revolutionary Surgical Robot Launch - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 28 (M)
Shares Float 16 (M)
Held by Insiders 1.4 (%)
Held by Institutions 7.4 (%)
Shares Short 566 (K)
Shares Short P.Month 319 (K)
Stock Financials
EPS -0.8
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.37
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -64.9 %
Return on Equity (ttm) -134.5 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.34
Qtrly Earnings Growth 0 %
Operating Cash Flow -8 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -2.73
PEG Ratio 0
Price to Book value 5.65
Price to Sales 0
Price to Cash Flow -7.68
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android